BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 18258917)

  • 1. Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development.
    Setoguchi R; Tachibana M; Naoe Y; Muroi S; Akiyama K; Tezuka C; Okuda T; Taniuchi I
    Science; 2008 Feb; 319(5864):822-5. PubMed ID: 18258917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Th-POK and Runx3 in T cell development in human thymoma.
    Tokunaga T; Hayashi A; Kadota Y; Shiono H; Inoue M; Sawabata N; Okumura M
    Autoimmunity; 2009; 42(8):653-60. PubMed ID: 19886737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cascading suppression of transcriptional silencers by ThPOK seals helper T cell fate.
    Muroi S; Naoe Y; Miyamoto C; Akiyama K; Ikawa T; Masuda K; Kawamoto H; Taniuchi I
    Nat Immunol; 2008 Oct; 9(10):1113-21. PubMed ID: 18776907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation in helper versus cytotoxic-lineage decision.
    Taniuchi I
    Curr Opin Immunol; 2009 Apr; 21(2):127-32. PubMed ID: 19361971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The zinc finger transcription factor Th-POK regulates CD4 versus CD8 T-cell lineage commitment.
    He X; He X; Dave VP; Zhang Y; Hua X; Nicolas E; Xu W; Roe BA; Kappes DJ
    Nature; 2005 Feb; 433(7028):826-33. PubMed ID: 15729333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal control of G1-phase progression is required for Th-POK/Runx3-mediated CD4/8 thymocyte cell fate decision.
    Sato T; Chiba T; Ohno S; Sato C; Sugoh T; Miyashita K; Akatsuka H; Hozumi K; Okada Y; Iida Y; Akatsuka A; Agata Y; Chiba M; Kohu K; Satake M; Tanabe H; Saya H; Habu S
    J Immunol; 2012 Nov; 189(9):4426-36. PubMed ID: 23018457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual functions of Runx proteins for reactivating CD8 and silencing CD4 at the commitment process into CD8 thymocytes.
    Sato T; Ohno S; Hayashi T; Sato C; Kohu K; Satake M; Habu S
    Immunity; 2005 Mar; 22(3):317-28. PubMed ID: 15780989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of CD4 in T cells committed to the cytotoxic lineage.
    Zou YR; Sunshine MJ; Taniuchi I; Hatam F; Killeen N; Littman DR
    Nat Genet; 2001 Nov; 29(3):332-6. PubMed ID: 11687799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the Runx transcription factors in thymocyte differentiation and in homeostasis of naive T cells.
    Egawa T; Tillman RE; Naoe Y; Taniuchi I; Littman DR
    J Exp Med; 2007 Aug; 204(8):1945-57. PubMed ID: 17646406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4-CD8 lineage commitment is regulated by a silencer element at the ThPOK transcription-factor locus.
    He X; Park K; Wang H; He X; Zhang Y; Hua X; Li Y; Kappes DJ
    Immunity; 2008 Mar; 28(3):346-58. PubMed ID: 18342007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of interleukin-4 in T helper type 1 cells by Runx/Cbf beta binding to the Il4 silencer.
    Naoe Y; Setoguchi R; Akiyama K; Muroi S; Kuroda M; Hatam F; Littman DR; Taniuchi I
    J Exp Med; 2007 Aug; 204(8):1749-55. PubMed ID: 17646405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the transcription factor Th-POK in CD4:CD8 lineage commitment.
    Kappes DJ; He X; He X
    Immunol Rev; 2006 Feb; 209():237-52. PubMed ID: 16448546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human CD6 gene is transcriptionally regulated by RUNX and Ets transcription factors in T cells.
    Arman M; Aguilera-Montilla N; Mas V; Puig-Kröger A; Pignatelli M; Guigó R; Corbí AL; Lozano F
    Mol Immunol; 2009 Jul; 46(11-12):2226-35. PubMed ID: 19446338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional control of T-cell development.
    Naito T; Tanaka H; Naoe Y; Taniuchi I
    Int Immunol; 2011 Nov; 23(11):661-8. PubMed ID: 21948191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonistic interplay between ThPOK and Runx in lineage choice of thymocytes.
    Egawa T; Taniuchi I
    Blood Cells Mol Dis; 2009; 43(1):27-9. PubMed ID: 19375362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Runx proteins are involved in regulation of CD122, Ly49 family and IFN-gamma expression during NK cell differentiation.
    Ohno S; Sato T; Kohu K; Takeda K; Okumura K; Satake M; Habu S
    Int Immunol; 2008 Jan; 20(1):71-9. PubMed ID: 18003603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development.
    Taniuchi I; Osato M; Egawa T; Sunshine MJ; Bae SC; Komori T; Ito Y; Littman DR
    Cell; 2002 Nov; 111(5):621-33. PubMed ID: 12464175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4-CD8 lineage commitment: an inside view.
    Kappes DJ; He X; He X
    Nat Immunol; 2005 Aug; 6(8):761-6. PubMed ID: 16034433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Runx-dependent and silencer-independent repression of a maturation enhancer in the Cd4 gene.
    Kojo S; Yasmin N; Muroi S; Tenno M; Taniuchi I
    Nat Commun; 2018 Sep; 9(1):3593. PubMed ID: 30185787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.